Cantel Medical Corp.

83.76+0.3800+0.46%Vol 298.90K1Y Perf 118.09%
Apr 9th, 2021 16:00 DELAYED
BID81.53 ASK84.99
Open83.44 Previous Close83.38
Pre-Market- After-Market-
 - -  - -%
Target Price
65.50 
Analyst Rating
Moderate Buy 2.25
Potential %
-21.80 
Finscreener Ranking
★+     45.10
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     40.15
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     53.25
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
+     26.10
Market Cap3.54B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
91.51 
Earnings Date
3rd Jun 2021

Today's Price Range

83.0283.98

52W Range

26.1989.10

5 Year PE Ratio Range

15.8076.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
2.35%
1 Month
9.75%
3 Months
1.55%
6 Months
76.86%
1 Year
118.09%
3 Years
-23.23%
5 Years
-37.61%
10 Years
100.29%

TickerPriceChg.Chg.%
CMD83.760.38000.46
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
1.90
2.70
0.55
1.26
1.90
Leverage Ratio 2.70
ProfitabilityValueIndustryS&P 500US Markets
46.00
10.20
17.80
10.10
4.57
RevenueValueIndustryS&P 500US Markets
1.06B
25.11
7.02
10.33
DividendsValueIndustryS&P 500US Markets
0.27
0.21
-9.56
3.15
Payout ratio32.00
Earnings HistoryEstimateReportedSurprise %
Q02 20210.490.7961.22
Q01 20210.360.90150.00
Q04 20200.080.24200.00
Q03 20200.140.1614.29
Q02 20200.680.61-10.29
Q01 20200.570.6514.04
Q04 20190.610.633.28
Q03 20190.550.550.00
Earnings Per EndEstimateRevision %Trend
4/2021 QR0.577.55Positive
7/2021 QR0.701.45Positive
7/2021 FY2.724.62Positive
7/2022 FY2.951.37Positive
Next Report Date3rd Jun 2021
Estimated EPS Next Report0.57
Estimates Count2
EPS Growth Next 5 Years %19.00
Volume Overview
Volume298.90K
Shares Outstanding42.27M
Trades Count3.70K
Dollar Volume44.43M
Avg. Volume563.97K
Avg. Weekly Volume414.99K
Avg. Monthly Volume489.87K
Avg. Quarterly Volume587.24K

Cantel Medical Corp. (NYSE: CMD) stock closed at 83.76 per share at the end of the most recent trading day (a 0.46% change compared to the prior day closing price) with a volume of 337.33K shares and market capitalization of 3.54B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3669 people. Cantel Medical Corp. CEO is George L. Fotiades.

The one-year performance of Cantel Medical Corp. stock is 118.09%, while year-to-date (YTD) performance is 6.21%. CMD stock has a five-year performance of -37.61%. Its 52-week range is between 26.19 and 89.1, which gives CMD stock a 52-week price range ratio of 91.51%

Cantel Medical Corp. currently has a PE ratio of 74.60, a price-to-book (PB) ratio of 4.28, a price-to-sale (PS) ratio of 3.29, a price to cashflow ratio of 16.90, a PEG ratio of 2.32, a ROA of 2.27%, a ROC of 5.71% and a ROE of 5.92%. The company’s profit margin is 4.57%, its EBITDA margin is 17.80%, and its revenue ttm is $1.06 Billion , which makes it $25.11 revenue per share.

Of the last four earnings reports from Cantel Medical Corp., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.57 for the next earnings report. Cantel Medical Corp.’s next earnings report date is 03rd Jun 2021.

The consensus rating of Wall Street analysts for Cantel Medical Corp. is Moderate Buy (2.25), with a target price of $65.5, which is -21.80% compared to the current price. The earnings rating for Cantel Medical Corp. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cantel Medical Corp. has a dividend yield of 0.27% with a dividend per share of $0.21 and a payout ratio of 32.00%.

Cantel Medical Corp. has a Buy technical analysis rating based on Technical Indicators (ADX : 9.16, ATR14 : 2.32, CCI20 : 0.46, Chaikin Money Flow : -0.37, MACD : -0.89, Money Flow Index : 30.10, ROC : 2.19, RSI : 50.93, STOCH (14,3) : 67.19, STOCH RSI : 1.00, UO : 44.05, Williams %R : -32.81), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cantel Medical Corp. in the last 12-months were: Ann E. Berman (Sold 5 500 shares of value $453 255 ), Brian R. Capone (Sold 300 shares of value $13 241 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.25
Moderate Buy
2.25
Moderate Buy
2.25

Cantel Medical Corp.

Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.

CEO: George L. Fotiades

Telephone: +1 973 890-7220

Address: 150 Clove Road, Little Falls 07424, NJ, US

Number of employees: 3 669

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

50%50%

Bearish Bullish

53%47%

News

Stocktwits